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Abstract
By injecting 131I-Lipiodol into lymphatics of the dorsum of dog feet, the distribution of
13JI in the lymph nodes and other principal organs as well as its histological effect were studied
periodically after the injection for the period of two months. The characteristic feature of J3JI
distribution was the fact that J31I was accumulated into lymph nodes markedly higher than in
any other organs and it was retained there over a long period of time. Histological examinations
of the lymph nodes revealed a marked lymphocytopenia, the loss of germinal center, practically
complete loss of lymphoid elements already 5 days after injection, and marked fibrosis. In the lung
a considerable J3JI·distribution could be seen in early stage:, but with lapse of time it decreased
rapidly. The distribution in other organs such as liver, spleen, bone marrow, kidney, ureter, bladder,
thyroid gland, pancreas, testicles and small and large intestines was negligible in amount, and any
specific histologic effect of irradiation could not be recognized in these organs including the lung.
From these results, the authors concluded that 131I-Lipiodol has a selective activity on lymph
nodes by injecting it via lymphatics and it is a safe method in clinical application to treat the
patients bearing malignant lymphoma or metastatic lymph nodes.
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Abstract: By injecting 131I-Lipiodol into lymphatics of the dor-
sum of dog feet, the distribution of 13JI in the lymph nodes and
other principal organs as well as its histological effect were studied
periodically after the injection for the period of two months. The
characteristic feature of J3JI distribution was the fact that J31I was
accumulated into lymph nodes markedly higher than in any other
organs and it was retained there over a long period of time. Histo-
logical examinations of the lymph nodes revealed a marked lympho-
cytopenia, the loss of germinal center, practically complete loss of
lymphoid elements already 5 days after injection, and marked fibrosis.
In the lung a considerable J3JI·distribution could be seen in early
stage:, but with lapse of time it decreased rapidly. The distribution
in other organs such as liver, spleen, bone marrow, kidney, ureter,
bladder, thyroid gland, pancreas, testicles and small and large in-
testines was negligible in amount, and any specific histologic effect
of irradiation could not be recognized in these organs including the
lung. From these results, the authors concluded that 131I-Lipiodol
has a selective activity on lymph nodes by injecting it via lymphatics
and it is a safe method in clinical application to treat the patients
bearing malignant lymphoma or metastatic lymph nodes.
Since the lymphography was technically established by KINMONTH in
1952 with the advent of a good oily contrast medium, it has been markedly
advanced in the past few years. This method has come to the use widely in
various fields of medicine and its diagnostic significance has been generally
recognized (1, 2). Furthermore, the lymphography with radioisotopes, i. e.
endolymphatic radiotherapy, is also being applied to the treatment for meta-
static lymph nodes and malignant lymphoma, and its usefulnesc;; has become
gradually recognized (3). However, scarcely seen are basic studies on the
reliability of endolymphatic radiotherapy for man, the findings on the
distribution of isotope in organs and its effects. Considering the importance
of this method for the treatment of malignant lymphoma, we have conducted
some experiments using dogs first, before its clinical application.
The purpose of this study is to confirm the significance and reliability
Of clinical application of endolymphatic radiotherapy by studying the qUaIl-
~~
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titative uptake and the effect of irradiation on lymph nodes and other organs
when 131J·Lipiodol is injected directly into the lymph vessels.
MATERIAL AND METHOD
Fifteen grownup dogs were anesthesized by intraperitoneal injection of
sodium pentobarbital dissolved in distilled water (350mg/20ml). Since there
was a considerable difference of anesthetic effect on individual animals, addi-
tional anesthesia was done when necessary. According to KINMONTH, after
shaving hairs and sterilizing on the dorsal side of both paws, 05 ml patent blue
was injected subcutaneously, the skin was cut open 1. 5-2 cm in lengths along
the lymph vessel stained blue, a lymphography needle was then inserted into
the exposed lymph vessel. By confirming the flow of saline solution into the
lymph vessel, radioisotope was injected. The radioisotope used was Iodinated
Triolein 131I·Lipiodol U. F. for intralymphatic injection (abbreviation: 13 11_
Lipiodol), a product of The Radiochemical Centre, England. It contains a
specific radioactivity of lOmCi/ml. To one paw was injected 2.5mCi or 5mCi
131I·Lipiodol dissolved into Lipiodol Ultrafluide, a conventional contrast
medium, not containing 1311, by adjusting the final volume to 2.5 ml. In
order to minimize the irradiation to the operator an automatic electric in-
jector was used at the speed of 1ml/lO minutes.
To see the effect of 1311 on the lymph nodes, 131I-Lipiodol and Lipiodol
without 1311 were injected into the dorsal lymph vessel of the left and right
paws respectively, and the both popliteal lymph nodes were compared with
each other. The amounts of 131I·distribution in the following organs were
measured with a well-type scintillation counter by sacrificing the animals at
intervals of 1,2,4 and 8 weeks after injection, i. e. retroperitoneal, popliteal
and cervical lymph nodes, lung, liver, spleen, thyroid, pancreas, kidney, small
and large intestines and testicles. For histologic examinations, various organs
were fixed with 10% formalin and stained with H·E solution. The amount
of 1311 flown into blood was estimated when 131I-Lipiodol is injected into
the dorsal lymph vessel of the dog paw; by the thoracic duct cannulation,
lymph was collected hourly for the first six hrs and was fractionated for the
additional six hrs, and the radioactivity was measured on each lymph sample.
RESULTS
1. 131J·distribution in various organs:
Table 1 shows the 131J·distribution in organs in terms of percentage to
the doses administered, 2.5 and 5mCi of 131J-Lipiodol, indicating that the
quantitative uptake by the popliteal and retroperitoneal lymph nodes is 5.4%
and 3.9% per I g one week later, respectively. This figure is markedly
higher than that in other organs, and at 4 weeks the concentration persists
as high as 4.9% and 3.3% respectively. This finding suggests that the
~ndolymphatic radiotherapy with 131I acts most selectively on the lym?h
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TABLE 1 131I-DISTRIBUTION IN VARIOUS ORGANS AFTER THE INTRALYMPHATlC
ADMINISTRATION OF 131I-LIPIODOL IN DOGS
61
weeks after
administration
organs A** B*** A
2
B A
4
B A
8
B
5.821
1.487
0.001
cervical 1. n. *
thyroid
lung
liver
spleen
pancreas
kidney
small intestine
large intestine
retroperitoneal 1. n.
popliteal 1. n.
testicle
0.006~ 0.018~ 0.005~ 0.022~ 0.006~ 0.006~
0.004 0.037 0.010 0.014 0.008 0.014
0.547 51.382 0.160 14.240 0.013 0.754
0.013 4.342 0.003 1.296 0.004 0.800
0.020 0.440 0.004 0.184 0.003 0.033
0.011 0.242 0.003 0.096 0.003 0.030
0.014 0.756 0.004 0.320 0.002 0.056
0.005 0.003 0.002
0.004 0.003 0.002
3.993 7.986 3.246 7.141 3.334 3.434
5.484 9.326 5.388 6.004 4.982 3.986
0.004 0.009
O. 001~ O. oo2~
0.002 0.004
0.004 0.326
0.003 0.798
0.002 0.032
<0.001 0.002
<0.001 0.004
<0.001
<0.001
2.772
1.239
<0.001
* 1. n.: lymph node
** A: percentage of doses distributed in one g tissue to the doses administered.
*** B: percentage of doses distributed in the whole organ to the doses administered.
- : not examined.
nodes and yields the most effective result. Relatively higher concentration
(0·.5%) as compared to other organs were observed in the lung one week later.
In contrast to the lymph nodes, the concentrations in the lung are decreased
rapidly to 0.1% and 0.01% at 2 weeks and 4 weeks later respectively. 131 1_
Lipiodol was found extremely low (0.004%) in the thyroid, and in the liver,
pancreas, kidney, large and small inte"tines and testicles the activity was
almost negligible.
2. Cumulative lymp h radioactivity of 1 :H! collected from dog thoracic duct (ex-
pressed in percent) :
Fig. 1 shows the results of estimation of 131 I released into blood via the
thoracic duct at the venous angle of dogs. About 35-45% of the dose admi-
nistered is released within six hrs, and by 12 hrs the amount reaches 65%.
However, as shown in Fig. 2, retroperitoneal lymph nodes in dogs are far
less in the numbers than that in man, making this result rather difficult to
be applied immediately to man.
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hours after 13lJ administration
Fig. I. Cummulative lymph radioactivity of 131J collected
from the thoracic duct after the intralymphatic administration
of 131J-Lipiodol in dogs. (expressed in percentage to the doses
administered)
Fig. 2. Retroperitoneal lymphogram taken immediately after
the intralymphatic administration of 131J-Lipiodol in the dog
4
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3. Histological examinations to find the effect of 1 311-Lipiodol on lymph nodes
and other organs:
By injecting 2. 5-5mCi 131I-Lipiodol and, as a control, 2.5 ml Lipiodol
VItrafluide not containing 131I into the dorsal lymph vessel of the left and
right paws respectively, lymph nodes were compared histologically. Fig. 3
shows the lymphogram of popliteal lymph node 24-48 hrs after 131I-injection,
and Fig. 4 that taken 24-48 hrs after injection of Lipiodol alone. The contrast
medium is extensively distributed within dilated sinusoids, and at a low
magnification there appears no appreciable difference between the two pic-
tures. At a high magnification, however, no damage to lymphocytes as seen
in the Fig. 5 but reactions to injected contrast medium can be observed in the
lymph nodes, into which Lipiodol Ultrafluide alone was injected. That is,
multinucleated foreign-body giant cells, hic;tiocytes, neutrophils and eosino-
phils are o;een in the above lymph nodes together with lymphoid hyperplasia.
In contrast, as seen in Fig. 6, destroyed lymphocytes, phagocytes ingesting
nuclei, large mononuclear cells and neutrophils are markedly increased in
the lymph nodes injected with 1311; and already by 24 hrs there can be'
observed a marked injurious effect on lymphocytes.
By five days after the 131J·injection, as shown in Fig. 7, there is observed
a marked decrease in lymphoid elements, the proliferation of interstitial cells
and a marked fibrosis. Two weeks later the lymph node presents a picture
like a fat marrow. By 4 and 8 weeks focal regenerations of lymphoid ele-
ments are seen as in Fig. 8. Other organs such as the thyroid, liver, spleen,
bone marrow, kidney, ureter, bladder, pancreas, testicles, small and large
intestines did not show any noteworthy changes, histologically.
DISCUSSION
Attempts at injecting radioisotopes into the lymph vessel for the treat-
ment of malignant lymphoma and metastatic lymph nodes had been carried
out quite early. In 1950 WALKER and in 1953 SHERMAN et ale (4, 5) conducted
the interstitial or subcutaneous injection of radioisotope into animals, but, as
the uptake of isotope into the lymph node was not sufficient, such a method
has not been applied to clinical practices.
WALKER (4) tried for the first time isotope injection, yttrium colloid,
directly into the rabbit lymph vessel, found the uptake of isotope into the
lymph nodes in a high concentration and pointed to a possibility of its appli-
cation in clinics. Since then, with the advent of 131I-Lipiodol and 32p_
Lipiodol, this method has become clinically available (3). For the clinical
application of endolymphatic radiotherapy, however, it is necessary to know
the quantitative uptake of isotope into organs, the amount of radioactivity
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Fig. 7. Section of the popliteal lymph node 5 days after the 131I-Lipiodol administra-
tIOn. H-E. /40.
Fig. 8. Section of the popliteal lymph node 4 weeks after the l:JlI-Lipiodol administra-
tion. H-E. X 40.
released into blood, and its effects on lymph nodes and other organs (6-11).
In the experiments conducted with dogs we have found that 51 ~/o of the
injected dose has reached lung while in the popliteal and retroperitoneal
lymph nodes only about 17o,~ is present one week after the injection. The
uptake into the lymph nodes in terms of % per 1 g tissue, however, was 6-10
times as much as that in the lung. What is more, while in the the lung the
radioactivity declines rapidly with lapse of time (2-8 weeks), in the lymph
------ --------- ---------------------------------- --------
Fig. 3. Section of the popliteal lymph node 24 hrs after the 131I-Lipiodol administration.
H-E. x40.
Fig. 4. Section of the popliteal lymph node 24 hrs after the administration of Lipiodol
Ultrafluide not containing 1311. H-E. ><40.
Fig. 5. Section of the popliteal lymph node 24 hrs after the administration of Lipiodol
Ultrafluide not containing 131 I. H-E. >< 400.
Fig. 6. Section of the popliteal lymph node 24 hrs after the l:llJ-Lipiodol administration.
H-E. >< 400. The large cell of higher magnification (lower rightl, shows the nucleophagia.
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node it was sustained at a considerable high concentration. The uptake in
the organs other than the lung by hematogenous dissemination is extremely
low and negligible, and no irradiation effect can be suspected. These results
seem to indicate that the radioisotope injected directly into the lymph vessel
has its strong irradiation effect selectively on the lymph nodes.
The amount of 131I-Lipiodol released in blood was estimated by the
thoracic duct cannulation; six hrs after the injection 30-40% of 1311 was
released into blood and at 12 hrs about 60%. Since the retroperiteal lymph
nodes of dogs are much less in numbers as compared with man, this result
cannot be directly applied to man. One must, however, bear the above fact
in mind in case we apply this technique clinically.
By the histologic examinations in the group administered with 131I·
Lipiodol, a marked lymphopenia and the dissappearance of germinal centers
were observed. By fifth day the lymph node lost practically all the lymphoid
elements and presented an appearance of fat marrow. In contrast, various
organs other than lymph nodes have shown not any findings suggestive of
irradiation injury at all.
It is generally known that the lymph node is radiosensitive, and that the
contrast medium injected is distributed homogenously in the lymph node with
malignant lymphoma and is retained for a long period of time. It could be
concluded that the endolympha~ic injection of 131I-Lipiodol would be a good
therapeutic method for malignant lymphoma, and that it is a safe method
because it did not cause any sid~-effects demonstrable in our experiment.
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